Sysmex Presents Academic Report in Effort to Create a Simple

/PRNewswire/ -- Sysmex Corporation (Chairman and CEO: Hisashi Ietsugu; hereafter, "Sysmex") and Eisai Co., Ltd. (CEO: Haruo Naito; hereafter, "Eisai") are...

Related Keywords

Mundelein , Illinois , United States , Japan , Tokyo , Kobe , Hyogo , Kengo Ishiki , Yuji Arimatsu , Atsushi Iwata , David Verbel , Shunsuke Watanabe , Toshiko Kubo , Masao Miura , Tomokazu Yoshida , Shigeki Iwanaga , Kei Hagino , Toshiyuki Sato , Akihiko Koyama , Yasuhiro Irino , Shobha Dhadda , Hayato Niiro , Kazuto Yamashita , Kota Nagai , Department Of Neurology , Sysmex Rd Center Americas , Eisai Inc , Drug Administration , Sysmex Corporation , Affairs Division , Asia Clinical Development Department , Business Incubation Division , Central Research Laboratories , Eisai Co Ltd , Research Laboratories , Incubation Division , Woodcliff Lake , Project Operations , Tokyo Metropolitan Geriatric Hospital , Immunoassay System , Discovery Study , Validation Study ,